GSH特异的人单链抗体计算机辅助结构研究

以还原型谷胱甘肽 (GSH)的两种衍物作为半抗原 ,从半人工合成的人单链抗体库中筛选得到了多株特异结合的单链抗体 .从中选择亲合力最强的单链抗体进行了基因的重组和测序 .根据由核苷酸测定结果而推导的氨基酸残基序列 ,用计算机模拟分析了两株单链抗体的空间结构 .结果显示单链抗体以二聚体形式存在 ,与单链抗体蛋白SDS_PAGE电泳结果相一致 .抗原结合部位———重链CDR3区位抗体的表面 ,且形成一个凹腔 ,因此可推测位于CDR3区的丝氨酸最可能参与硒化反应     

可溶性人源含硒抗体酶GPx的研究

对噬菌体展示人单链抗体库进行筛选,得到与半抗原S-二硝基苯取代的谷胱甘肽二丁酯特异结合的单链抗体3B10。用计算机模拟分析了单链抗体的空间结构,发现抗原结合的CDR3区位于抗体的表面,推测其可能进一步参加硒化反。利用突变引物,在大肠杆菌中表达了可溶性抗体蛋白,并用化学方法将催化必需基团硒代半胱氨酸（Sec）组装到3B10抗原结合部位,获得了具有谷胱甘肽过氧化酶活力的人源抗体酶。动力学研究结果表明,抗体酶和天然酶一样,符合乒乓反应机制。     

二乙氧基硫代磷酸酯类有机磷农药单链抗体的制备及广谱特异性

从分泌抗二乙氧基硫代磷酸酯类有机磷农药(DPPs)单克隆抗体(MAb)的杂交瘤细胞系(12C2)中提取了总RNA, 经RT-PCR反转录成cDNA, 设计带linker引物, 采用重叠延伸PCR制备单链抗体(scFv)基因, 将其克隆到噬菌体载体p3MH中, 构建成噬菌体单链抗体表达载体, 转化大肠杆菌表达出噬菌体表面展示scFv, 对经过Phage-ELISA鉴定的阳性克隆进行噬菌体外壳蛋白基因geneⅢ的去除, 用IPTG诱导其可溶性表达, 对表达产物进行SDS-PAGE, Western-Blot及ELISA鉴定, 并与亲本MAb进行性能对比. 结果表明, 可溶性表达的scFv分子量为27000; scFv与DPPs的交叉反应率比其亲本MAb提高了1.3~3.5倍, 表明其广谱特异性有所提高. 由于scFv与MAb相比具有诸多优点, 因此本研究为有机磷农药多残留检测方法的建立提供了一种更广谱、 更灵敏的新型识别分子.     

氧氟沙星噬菌体库的构建、筛选及抗体结构模拟

应用噬菌体展示和重组抗体技术制备抗氧氟沙星单链抗体(scFv)库,筛选获得氧氟沙星特异性噬菌体scFv以及同源模拟其三维结构。将从氧氟沙星杂交瘤细胞提取的总RNA,用RT-PCR反转录合成cDNA,以针对鼠源重链可变区(VH)及轻链可变区(VL)基因的兼并引物,扩增获得VH和VL可变区基因,通过SOE-PCR法将VH基因和VL基因通过柔性多肽Linker(Gly4Ser)3拼接成全长scFv基因片段,将双酶切后的scFv基因片段插入T7噬菌体,经体外包装后转化宿主菌BLT5403,成功构建库容量为3×105pfu/mL的抗体库,经4轮吸附-洗脱-扩增的富集,采用直接竞争ELISA筛选到4个特异性噬菌体scFv,运用Expasy软件模拟特异性scFv的三维结构。为进一步大量表达氧氟沙星单链抗体奠定了基础。     

抗肿瘤双特异免疫导向治疗制剂CAtin的表达及活性分析

结合生物信息学方法与已知癌胚抗原(Carcinoembryonic antigen, CEA)特异性单链抗体(Single chain Fv fragment, scFv)核苷酸序列, 经分子设计和密码子优化后, 通过化学方法合成CEA二硫键稳定性单链抗体(Disulfide stabilized single chain Fv fragments, scdsFv)基因片段. 将凋亡素基因(Apoptin)通过一段柔性连接肽(Linker)连接在CEA scdsFv基因下游, 并克隆入大肠杆菌表达载体质粒pET28a, 转化BL21感受态菌后经异丙基-β-D-硫代半乳糖苷(Isopropyl β-D-1-thiogalactopyranoside, IPTG)诱导, 表达融合蛋白CAtin. SDS-PAGE和Western-Blot分析表明, 目的蛋白得到良好表达, 经条件优化后表达量最高可达44.1 mg/L. 融合蛋白经分步洗涤法和谷胱甘肽对表达的目的蛋白进行初步纯化和复性后, 利用人肝癌细胞(HCC)对所制备融合蛋白进行亲和力测定、细胞结合活性测定和特异性细胞杀伤活性分析. 结果显示, 所制备融合蛋白不仅能够有效地与上述肿瘤细胞结合, 并对其具有明显的杀伤活性, 表明成功制备了具有特异性识别和特异性杀伤活性的双特异抗肿瘤免疫导向制剂.     

量子点与人源抗谷胱甘肽单链抗体的连接与表征

用已构建的表达载体pPELB-B3, 在大肠杆菌Rosetta中可溶性表达人源抗谷胱甘肽(GSH)单链抗体B3(scFv-B3), 经Ni2+螯合亲和层析纯化后, 用点印迹法验证了其与GSH结合的特异性. 将水相合成的半导体纳米粒子(半导体量子点, QDs)在N-羟基琥珀酰亚胺(NHS)和1-乙基-3-(3-二甲基氨基丙基)碳酰二亚胺盐酸盐(EDC)的作用下, 与scFvs连接. 光谱分析和膜印迹结果表明, scFvs成功地共价连接到QDs表面, 所得的QD-scFvs复合物能够较好地识别GSH. 荧光显微镜观察QD-scFvs与人乳腺癌细胞MCF-7的作用结果, 初步判断QD-scFvs能够跨膜进入细胞.     

基于定点突变的抗克百威单链抗体的亲和力成熟

为获得亲和力更高的抗克百威(CBF)单链抗体(scFv), 从抗CBF scFv氨基酸序列出发, 通过同源模建获得抗体模型, 找出抗体中的活性口袋区域, 进而将小分子药物与抗体进行分子对接, 发现疏水作用和氢键对于抗体亲和力具有重要作用. 进一步对口袋内亲水氨基酸残基HArg40和LHis38进行模拟替换, 再进行分子对接分析, 发现当以亮氨酸为突变氨基酸时, 对接评分最高. 在此基础上, 通过构建突变scFv基因及可溶性表达, 采用ELISA法对进化后的单链抗体(evoscFv)进行了鉴定. 结果表明, evoscFv对CBF的IC₅₀值为18.11 μg/L, 低于野生型抗体的27.25 μg/L, 亲和解离常数K_d为4.06×10^-8 mol/L, 相对亲和力比野生型scFv提高了2.23倍, 说明通过分子对接分析及对抗体活性口袋中氨基酸残基进行替换, 获得了一个亲和力更高的突变体抗体.     

一种检测二恶英的单链抗体方法

本发明公开了一种检测二恶英的单链抗体方法。该单链抗体基因来源于小鼠，克隆到表达载体pET20b，在大肠杆菌BL21中表达，利用表达蛋白上带有的His-tag标记可通过亲和层析纯化单链抗体蛋白，并利用C-myc标记检测单链抗体蛋白。本发明克隆到鼠源的抗二恶英类化学物质的单链抗体，该抗体能应用于检测二恶英类化学物质，检测成本低，应用前景广泛。     

具有GPX活力的抗体片段Fv的制备和性质

具有谷胱甘肽(GSH)结合部位的鼠抗体3H₄(IgM)经胃蛋白酶水解,产生分子量为25000的抗体Fv片段,用荧光滴定法测定了它与GSH的亲和常数K_a=1.17×10₇L/mol.该片段经苯甲基磺酰氟活化,再经NaHSe作用,其结合部位的丝氨酸被突变为谷胱甘肽过氧化物酶(GPX)的催化基团硒代半胱氨酸.突变后的Fv片段表现出很高的GPX活性,其活力高达2500U/μmol,称为Fv抗体酶.动力学分析表明,Fv酶的最适温度为55℃,最适pH为7.0,催化机制为乒乓机制,米氏常数分别为:K_m(GSH)=4.16×10^-3mol/L,K_m(H₂O₂)=2.8×10^-4mol/L.     

噬菌体展示技术制备甲氧基有机磷农药抗独特型抗体

抗独特性抗体可用于建立针对农药等小分子物质的非竞争免疫检测模式.本研究将甲氧基有机磷农药通用半抗原(S-羧甲基-O,O-二甲基二硫代磷酸酯,CMP)连接至琼脂糖凝胶,进而对甲氧基有机磷农药广谱特异性抗体进行纯化;以纯化抗体为固相抗原,以人源scFv抗体库(Tomlinson I+J)为抗体源,进行抗独特型抗体的筛选;利...     

Construction of Human Nonimmune Library and Selection of scFvs Against IL-33

Interleukin (IL) 33 plays very important roles in inflammatory and allergic diseases. To select human single-chain Fv fragments (scFvs) against IL-33, a nonimmune phage library system was constructed. The full-length cDNA library was synthesized for amplification of the variable heavy chain (V_H) and variable light chain (V_L). By overlapping extension PCR for splicing V_H and V_L, the full-length scFv library DNA were amplified and then transformed into Escherichia coli TG1. The scFv library was constructed successfully which contained 2.5?×?10⁸ independent clones with full-length scFv inserts. The results of fingerprint maps of the scFvs by BstN I and DNA sequencing from the library at random proved that the library was diverse. The human IL-33 was amplified, expressed, and purified. The purified IL-33 with bioactivity was biotinylated and used as antigen for selection of scFv library by phage display. After three rounds of affinity selection, about 30?% of clones have specific binding activity with IL-33. Five of those with good binding activity were transformed into E. coli strain HB2151 for soluble expression. The selected scFvs were further identified by western blot and sequencing. Those selected scFvs could be used for further research of their effect on inflammatory and allergic diseases such as asthma by blockade of IL-33.     

Phylogenetic characterization of a mixed microbial community capable of degrading carbon tetrachloride

Two bacterial communities (NO92 and GBS) capable of degrading carbon tetrachloride (CT) were enriched from in-house CT-contaminated water. These communities are able to degrade CT in the presence of toluene. To characterize the community structure and diversity, one enrichment (NO92) was subjected to 16S ribosomal RNA (rRNA) gene-based molecular analysis. The 16S rRNA genes were amplified from the bulk genomic community DNA and cloned into plasmid vectors. Unique 16S rRNA gene clones, i.e., phylotypes, were detected by four tetrameric restriction enzymes. Together, 123 16S rRNA gene clones were obtained; thirty-one showed different restriction fragment length polymorphism (RFLP) patterns. About 73% of the clones belong to two dominant RFLP patterns. Phylogenetic analysis based on the partial 16S rRNA gene sequences of 10 major phylotypes showed that all the phylotypes that were sequenced were affiliated with the high G+C Gram-positive bacteria. Whereas seven of the phylotypes (∼80% of the clones) were closely related to Rhodococcus, the other three (∼5% of the clones) were related to Curtobacterium. These results suggest that this CT-degrading community is diverse but is predominated by closely related bacterial groups.     

Novel Selenium-containing Human Single-chain Variable Fragment with Glutathione Peroxidase Activity from Computer-aided Molecular Design

In order to enhance the glutathione peroxidase(GPX) catalytic activity of the selenium-containing single-chain variable fragments(Se-scFv), a novel human scFv was designed on the basis of the structure of human antibody and optimized via bioinformatics methods such as homologous sequence analysis, three-dimensional(3D) model building, binding-site analysis and docking. The DNA sequence of the new human scFv was synthesized and cloned into the expression vector pET22b(+), then the scFv protein was expressed in soluble form in Escherichia coli BL21(DE3) and purified by Ni2+-immobilized metal affinity chromatography(IMAC). The serine residue of scFv in the active site was converted into selenocysteine(Sec) with the chemical modification method, thus, the human Se-scFv with GPX activity was obtained. The GPX activity of the Se-scFv protein was characterized. Compared with other Se-scFv, the new human Se-scFv showed similar efficiency for catalyzing the reduction of hydrogen peroxide by glutathione. It exhibited pH and temperature dependent catalytic activity and a typical ping-pong kinetic mecha- nism.     

Decoding Selection Bias Imparted by Unpaired Cysteines: a Tug of War Between Expression and Affinity

In a recombinant antibody scFv format, the presence of an unpaired cysteine (Cys) is implicated in reduced soluble expression and inefficient presentation in phage display. Compared to other species, antibodies derived from rabbits are more likely to contain this unpaired Cys residue at position 80 (Cys80), when generated in a scFv format. In a screening campaign to isolate rabbit scFv against cardiac troponin I (cTnI), it was found that, a large proportion of isolated cTnI-specific clones contained unpaired Cys80. To analyze the factors that led to the selection of anti-cTnI Cys80 scFv, after five rounds of biopanning, the biopanning experiments were repeated with a Cys80 scFv (MG4_Cys), its alanine variant (MG4_Ala), and an irrelevant high expressing scFv control. It was found that the selection and subsequent enrichment of MG4_Cys scFv was ousted by the superior expressing variant MG4_Ala, indicating that the Cys80 scFv was selected primarily due to its affinity. It is evident that phage-based selection is influenced by specific sequence characteristics affecting the expression as well as the binding specificity and this needs to be taken into account for selection of optimal antibody derivatives.     

Identification of a Neutralizing scFv Binding to Human Vascular Endothelial Growth Factor 165 (VEGF165) Using a Phage Display Antibody Library

Vascular endothelial growth factor (VEGF) is a multifunctional cytokine that plays a major role in angiogenesis. Alternative splicing causes the production of several different isoforms (VEGF121, 145, 165, 183, 189, 206). VEGF is essential for tumor angiogenesis, and several studies have correlated elevated VEGF levels with tumor stage, metastases, and progression. We now report the isolation by phage display of human single-chain antibody fragment (scFv) anti-VEGF165. After four rounds of panning against VEGF165, 40 out of 90 phage clones displayed VEGF165-binding activity. One of the positive clones, designated B8, bound to VEGF165 with relatively high affinity and neutralized VEGF165 bioactivity in vitro. The B8 clone was expressed in the soluble form in Escherichia coli HB2151 and purified by immobilized metal affinity chromatography. The purified scFv recognized VEGF165 with the K _D of 1.80 × 10⁻⁸ M without cross-reaction to VEGF121. In addition to binding, the purified scFv could does-dependently inhibit VEGF165-induced human umbilical vein-derived endothelial cells proliferation. Together with its fully human mature, B8 scFv may have therapeutic implications in therapy of angiogenesis-dependent diseases.     

Screening of scFvs against cTnI from Phage Display Antibody Library and Their Expression in E.coli Rosetta

Introduction CardiactroponinI(cTnI),aspecificproteinof cardiacmusclecells,showsa40%dissimilarity withskeletaltroponinI(sTnI)inaminoacidse- quence.Moreover,humancardiacTnIhas31addi- tionalresiduesonitsN-terminalend,whichare notpresentinskeletalforms,thusprovidingahigh potentialforobtainingcardiac-specificantibod- ies[1,2].Themolecularweightofthisproteinis29 kDaandtherefore,itwillbereleasedreasonably rapidlyafteracutemyocardialinfarction(AMI). CTnIoftenappearsinbloodwithinafewhoursaf- ter…     

Routes to covalent catalysis by reactive selection for nascent protein nucleophiles

Reactivity-based selection strategies have been used to enrich combinatorial libraries for encoded biocatalysts having revised substrate specificity or altered catalytic activity. This approach can also assist in artificial evolution of enzyme catalysis from protein templates without bias for predefined catalytic sites. The prevalence of covalent intermediates in enzymatic mechanisms suggests the universal utility of the covalent complex as the basis for selection. Covalent selection by phosphonate ester exchange was applied to a phage display library of antibody variable fragments (scFv) to sample the scope and mechanism of chemical reactivity in a naive molecular library. Selected scFv segregated into structurally related covalent and noncovalent binders. Clones that reacted covalently utilized tyrosine residues exclusively as the nucleophile. Two motifs were identified by structural analysis, recruiting distinct Tyr residues of the light chain. Most clones employed Tyr32 in CDR-L1, whereas a unique clone (A.17) reacted at Tyr36 in FR-L2. Enhanced phosphonylation kinetics and modest amidase activity of A.17 suggested a primitive catalytic site. Covalent selection may thus provide access to protein molecules that approximate an early apparatus for covalent catalysis.